Cargando…

The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells

BACKGROUND: Proper repair and restart of stressed replication forks requires intact homologous recombination (HR). HR at stressed replication forks can be initiated by the 5′ endonuclease EEPD1, which cleaves the stalled replication fork. Inherited or acquired defects in HR, such as mutations in bre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hromas, Robert, Kim, Hyun-Suk, Sidhu, Gurjit, Williamson, Elizabeth, Jaiswal, Aruna, Totterdale, Taylor A., Nole, Jocelyn, Lee, Suk-Hee, Nickoloff, Jac A., Kong, Kimi Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693420/
https://www.ncbi.nlm.nih.gov/pubmed/29145865
http://dx.doi.org/10.1186/s13058-017-0912-8
_version_ 1783279935245254656
author Hromas, Robert
Kim, Hyun-Suk
Sidhu, Gurjit
Williamson, Elizabeth
Jaiswal, Aruna
Totterdale, Taylor A.
Nole, Jocelyn
Lee, Suk-Hee
Nickoloff, Jac A.
Kong, Kimi Y.
author_facet Hromas, Robert
Kim, Hyun-Suk
Sidhu, Gurjit
Williamson, Elizabeth
Jaiswal, Aruna
Totterdale, Taylor A.
Nole, Jocelyn
Lee, Suk-Hee
Nickoloff, Jac A.
Kong, Kimi Y.
author_sort Hromas, Robert
collection PubMed
description BACKGROUND: Proper repair and restart of stressed replication forks requires intact homologous recombination (HR). HR at stressed replication forks can be initiated by the 5′ endonuclease EEPD1, which cleaves the stalled replication fork. Inherited or acquired defects in HR, such as mutations in breast cancer susceptibility protein-1 (BRCA1) or BRCA2, predispose to cancer, including breast and ovarian cancers. In order for these HR-deficient tumor cells to proliferate, they become addicted to a bypass replication fork repair pathway mediated by radiation repair protein 52 (RAD52). Depleting RAD52 can cause synthetic lethality in BRCA1/2 mutant cancers by an unknown molecular mechanism. METHODS: We hypothesized that cleavage of stressed replication forks by EEPD1 generates a fork repair intermediate that is toxic when HR-deficient cells cannot complete repair with the RAD52 bypass pathway. To test this hypothesis, we applied cell survival assays, immunofluorescence staining, DNA fiber and western blot analyses to look at the correlation between cell survival and genome integrity in control, EEPD1, RAD52 and EEPD1/RAD52 co-depletion BRCA1-deficient breast cancer cells. RESULTS: Our data show that depletion of EEPD1 suppresses synthetic lethality, genome instability, mitotic catastrophe, and hypersensitivity to stress of replication of RAD52-depleted, BRCA1 mutant breast cancer cells. Without HR and the RAD52-dependent backup pathway, the BRCA1 mutant cancer cells depleted of EEPD1 skew to the alternative non-homologous end-joining DNA repair pathway for survival. CONCLUSION: This study indicates that the mechanism of synthetic lethality in RAD52-depleted BRCA1 mutant cancer cells depends on the endonuclease EEPD1. The data imply that EEPD1 cleavage of stressed replication forks may result in a toxic intermediate when replication fork repair cannot be completed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-017-0912-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5693420
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56934202017-11-24 The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells Hromas, Robert Kim, Hyun-Suk Sidhu, Gurjit Williamson, Elizabeth Jaiswal, Aruna Totterdale, Taylor A. Nole, Jocelyn Lee, Suk-Hee Nickoloff, Jac A. Kong, Kimi Y. Breast Cancer Res Research Article BACKGROUND: Proper repair and restart of stressed replication forks requires intact homologous recombination (HR). HR at stressed replication forks can be initiated by the 5′ endonuclease EEPD1, which cleaves the stalled replication fork. Inherited or acquired defects in HR, such as mutations in breast cancer susceptibility protein-1 (BRCA1) or BRCA2, predispose to cancer, including breast and ovarian cancers. In order for these HR-deficient tumor cells to proliferate, they become addicted to a bypass replication fork repair pathway mediated by radiation repair protein 52 (RAD52). Depleting RAD52 can cause synthetic lethality in BRCA1/2 mutant cancers by an unknown molecular mechanism. METHODS: We hypothesized that cleavage of stressed replication forks by EEPD1 generates a fork repair intermediate that is toxic when HR-deficient cells cannot complete repair with the RAD52 bypass pathway. To test this hypothesis, we applied cell survival assays, immunofluorescence staining, DNA fiber and western blot analyses to look at the correlation between cell survival and genome integrity in control, EEPD1, RAD52 and EEPD1/RAD52 co-depletion BRCA1-deficient breast cancer cells. RESULTS: Our data show that depletion of EEPD1 suppresses synthetic lethality, genome instability, mitotic catastrophe, and hypersensitivity to stress of replication of RAD52-depleted, BRCA1 mutant breast cancer cells. Without HR and the RAD52-dependent backup pathway, the BRCA1 mutant cancer cells depleted of EEPD1 skew to the alternative non-homologous end-joining DNA repair pathway for survival. CONCLUSION: This study indicates that the mechanism of synthetic lethality in RAD52-depleted BRCA1 mutant cancer cells depends on the endonuclease EEPD1. The data imply that EEPD1 cleavage of stressed replication forks may result in a toxic intermediate when replication fork repair cannot be completed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-017-0912-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-16 2017 /pmc/articles/PMC5693420/ /pubmed/29145865 http://dx.doi.org/10.1186/s13058-017-0912-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hromas, Robert
Kim, Hyun-Suk
Sidhu, Gurjit
Williamson, Elizabeth
Jaiswal, Aruna
Totterdale, Taylor A.
Nole, Jocelyn
Lee, Suk-Hee
Nickoloff, Jac A.
Kong, Kimi Y.
The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells
title The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells
title_full The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells
title_fullStr The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells
title_full_unstemmed The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells
title_short The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells
title_sort endonuclease eepd1 mediates synthetic lethality in rad52-depleted brca1 mutant breast cancer cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693420/
https://www.ncbi.nlm.nih.gov/pubmed/29145865
http://dx.doi.org/10.1186/s13058-017-0912-8
work_keys_str_mv AT hromasrobert theendonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT kimhyunsuk theendonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT sidhugurjit theendonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT williamsonelizabeth theendonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT jaiswalaruna theendonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT totterdaletaylora theendonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT nolejocelyn theendonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT leesukhee theendonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT nickoloffjaca theendonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT kongkimiy theendonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT hromasrobert endonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT kimhyunsuk endonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT sidhugurjit endonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT williamsonelizabeth endonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT jaiswalaruna endonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT totterdaletaylora endonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT nolejocelyn endonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT leesukhee endonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT nickoloffjaca endonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells
AT kongkimiy endonucleaseeepd1mediatessyntheticlethalityinrad52depletedbrca1mutantbreastcancercells